Cytokinetics
@Cytokinetics
We are developing potential medicines to improve the healthspan of people with diseases of impaired muscle function. 2024 Great Place to Work-Certified🏅
$CYTK: We will report our second quarter 2025 financial results on August 7. Following the announcement, senior management will host a conference call to discuss the results. bit.ly/45jJKSm

We’re at the AAHFN 21st Annual Meeting in Savannah! Come visit us at booth #307! #AAHFN2025 #HeartFailure #HCM #cardiotwitter

At #AAHFN2025, join us for the industry theater: "Seeing the Unseen: Revealing Clues to Identify Obstructive Hypertrophic Cardiomyopathy." Speakers will review the impact of oHCM on patient well-being, discuss diagnosis and more. bit.ly/4jfZlX0 #HCM #CardioTwitter
Last week, we hosted the second annual #CLIMB25. Thank you to everyone from academia and industry who attended and presented, contributing to meaningful discussions advancing our understanding of muscle-related diseases and disorders.
$CYTK: We are participating in the upcoming @Jefferies Global Healthcare Conference 2025, where we'll join industry leaders and investors to discuss current global trends in healthcare. bit.ly/43RnRsS #JefferiesHealthcare

We're heading to the AAHFN 21st Annual Meeting! The AAHFN Annual Meeting is dedicated to heart failure nursing, and we're excited to engage in discussions to help improve and advance heart failure care. bit.ly/4jfZlX0 #AAHFN2025 #HeartFailure #HCM #CardioTwitter

We’re at the @escardio #HeartFailure2025 in Belgrade, Serbia. Come visit us at booth A10. #HCM #HFA_ESC #heartfailure #CardioTwitter

Cytokinetics will be presenting at the @escardio #HeartFailure2025 Congress. To learn more about the Congress: bit.ly/4dcfgnu #CardioTwitter

$CYTK: Today, we report our first quarter 2025 financial results, and our senior management team will provide more details in a conference call at 4:30 p.m. ET. bit.ly/3GJ7OnQ

It’s Heart Failure Awareness Days in Europe! As we look ahead to ESC #HeartFailure2025, we're proud to raise awareness around #heartfailure and help inspire change. Learn more about heart failure: bit.ly/3RCQ7Zv #HeartFailureAwareness

We'll be attending the European Society of Cardiology's #HeartFailure2025 taking place in Belgrade, Serbia, May 17–20. The congress brings together experts to discuss the prevention, diagnosis and treatment of #heartfailure. bit.ly/4iGszxI #HCM #HFA_ESC #CardioTwitter

$CYTK: We will be participating in upcoming investor conferences hosted by Citizens and RBC Capital Markets. bit.ly/42OWfmw

Today our CEO Robert Blum presented at #SDDS2025 hosted by @StanfordCVI. He spoke about our scientific innovation, the pivotal role of business development, and the fortitude required to advance science and build a company.

We're heading to ISPOR 2025! Join our HEOR team in Montreal May 13 – 16. ISPOR 2025 underscores the importance of health economics and outcomes research in transforming healthcare systems. bit.ly/42WFCpd #ISPORAnnual

Registration is now open for our 2nd annual CLIMB Symposium taking place on May 30 in San Francisco. CLIMB brings together scientists, researchers, and emerging professionals to share innovative research in the field of muscle biology. ClimbSymposium.com #CLIMB25




We're looking forward to attending Asembia’s Specialty Pharmacy Summit where we’ll have the chance to connect with leaders and experts in specialty pharmacy to share insights, discuss trends and help improve patient access and care. bit.ly/4itmO6G #asembia25

$CYTK: We will report our first quarter 2025 financial results on May 6. Following the announcement, senior management will host a conference call to discuss the results. bit.ly/44Bbz8J

We recently published our 2024 #CorporateResponsibility Report. The report provides an in-depth look into our initiatives, which are guided by value-based decision making with the intention to prioritize long-term beneficial outcomes for all stakeholders. bit.ly/42a6d2K
In 2024, like a carefully choreographed performance, each initiative that propelled us closer to realizing our mission of meaningfully improving the lives of patients through global access to our potential medicines. bit.ly/3E1Rtda

At @HeartNurses 2025 Cardiovascular Nursing Symposium, be sure to join us for a disease state theater presentation: "The Critical Role of Advanced Practice Providers and Nurses in Diagnosis and Management of Patients with Hypertrophic Cardiomyopathy.” bit.ly/4iWsWW0 #HCM